< Back to previous page
Project
Metformin as RenoProtector in NonDiabetic Patients with Progressive Chronic Kidney Disease (CKD stages 2, 3A and 3B): a multicentre, practice-oriented, repurposing, double-blind, placebo-controlled, randomized clinical trial (RenoMet)
This multi-centre, practice-oriented, repurposing, double-blind, placebo-controlled, randomized clinical trial evaluates the effect of metformin treatment on the progression of chronic renal failure
Date:26 Feb 2019 → Today
Keywords:RENAL SCREENING
Disciplines:Kidney diseases
Project type:Collaboration project